RETATRUTIDE

Retatrutide (GLP-3) is a synthetic multi-agonist peptide designed to interact with GLP-1, GIP, and glucagon receptor pathways. Research covers triple-incretin signaling and metabolic pathway analysis.

Compound

Retatrutide (LY3437943), triple GIP / GLP-1 / glucagon receptor agonist

CAS number

2381089-83-2

Molecular weight

4731.3 g/mol

Form

Lyophilized powder in a sealed glass vial

Strength

10mg / 15mg / 20mg / 30mg per vial

Purity

>99% (brand-wide standard), measured 99.63% on the current lot

Testing

HPLC purity, mass spectrometry identity, bacterial endotoxin (pass), run by Horizon Analytical

Documentation

Lot 7922284, tested Aug 22, 2026 certificate of analysis

Storage

Lyophilized: sealed at -20°C, protected from light and moisture.

Origin

Vialed, finished, tested and shipped in the USA

Intended use

Research use only. Not for human or veterinary use.

Pricing and ordering are available to signed-in research accounts.